BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18194664)

  • 1. Mass spectrometric identification of lysine residues of heme oxygenase-1 that are involved in its interaction with NADPH-cytochrome P450 reductase.
    Higashimoto Y; Sugishima M; Sato H; Sakamoto H; Fukuyama K; Palmer G; Noguchi M
    Biochem Biophys Res Commun; 2008 Mar; 367(4):852-8. PubMed ID: 18194664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of cytochrome P450 17alpha with NADPH-cytochrome P450 reductase, investigated using chemical modification and MALDI-TOF mass spectrometry.
    Nikfarjam L; Izumi S; Yamazaki T; Kominami S
    Biochim Biophys Acta; 2006 Jun; 1764(6):1126-31. PubMed ID: 16713412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein/protein interactions in the mammalian heme degradation pathway: heme oxygenase-2, cytochrome P450 reductase, and biliverdin reductase.
    Spencer AL; Bagai I; Becker DF; Zuiderweg ER; Ragsdale SW
    J Biol Chem; 2014 Oct; 289(43):29836-58. PubMed ID: 25196843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of NADPH in the interaction between heme oxygenase-1 and cytochrome P450 reductase.
    Higashimoto Y; Sakamoto H; Hayashi S; Sugishima M; Fukuyama K; Palmer G; Noguchi M
    J Biol Chem; 2005 Jan; 280(1):729-37. PubMed ID: 15516695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of heme oxygenase-1 from cyanobacterium Synechocystis sp. PCC 6803 in complex with heme.
    Sugishima M; Migita CT; Zhang X; Yoshida T; Fukuyama K
    Eur J Biochem; 2004 Nov; 271(22):4517-25. PubMed ID: 15560792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of lysine and arginine residues of cytochrome P450 in the interaction between cytochrome P4502B1 and NADPH-cytochrome P450 reductase.
    Shen S; Strobel HW
    Arch Biochem Biophys; 1993 Jul; 304(1):257-65. PubMed ID: 8323289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reactions of heme- and verdoheme-heme oxygenase-1 complexes with FMN-depleted NADPH-cytochrome P450 reductase. Electrons required for verdoheme oxidation can be transferred through a pathway not involving FMN.
    Higashimoto Y; Sato H; Sakamoto H; Takahashi K; Palmer G; Noguchi M
    J Biol Chem; 2006 Oct; 281(42):31659-67. PubMed ID: 16928691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the electron transfer from an open form of NADPH-cytochrome P450 oxidoreductase to heme oxygenase.
    Sugishima M; Sato H; Higashimoto Y; Harada J; Wada K; Fukuyama K; Noguchi M
    Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2524-9. PubMed ID: 24550278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of danthron as an isoform-specific inhibitor of HEME OXYGENASE-1/cytochrome P450 reductase interaction with anti-tumor activity.
    Chou YT; Hsu FF; Hu DY; Chen YC; Hsu YH; Hsu JT; Chau LY
    J Biomed Sci; 2018 Jan; 25(1):6. PubMed ID: 29361943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The binding sites on human heme oxygenase-1 for cytochrome p450 reductase and biliverdin reductase.
    Wang J; de Montellano PR
    J Biol Chem; 2003 May; 278(22):20069-76. PubMed ID: 12626517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and characterization of full-length human heme oxygenase-1: the presence of intact membrane-binding region leads to increased binding affinity for NADPH cytochrome P450 reductase.
    Huber WJ; Backes WL
    Biochemistry; 2007 Oct; 46(43):12212-9. PubMed ID: 17915953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human heme oxygenase-1 efficiently catabolizes heme in the absence of biliverdin reductase.
    Reed JR; Huber WJ; Backes WL
    Drug Metab Dispos; 2010 Nov; 38(11):2060-6. PubMed ID: 20679134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of oxaporphyrin ring of CO-bound α-verdoheme complexed with heme oxygenase-1 by NADPH-cytochrome P450 reductase.
    Sato H; Higashimoto Y; Sakamoto H; Sugishima M; Shimokawa C; Harada J; Palmer G; Noguchi M
    J Inorg Biochem; 2011 Feb; 105(2):289-96. PubMed ID: 21194630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-Terminal membrane spanning region of human heme oxygenase-1 mediates a time-dependent complex formation with cytochrome P450 reductase.
    Huber Iii WJ; Scruggs BA; Backes WL
    Biochemistry; 2009 Jan; 48(1):190-7. PubMed ID: 19123922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in the Understanding of the Reaction Chemistries of the Heme Catabolizing Enzymes HO and BVR Based on High Resolution Protein Structures.
    Sugishima M; Wada K; Fukuyama K
    Curr Med Chem; 2020; 27(21):3499-3518. PubMed ID: 30556496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The iron chaperone poly(rC)-binding protein 2 forms a metabolon with the heme oxygenase 1/cytochrome P450 reductase complex for heme catabolism and iron transfer.
    Yanatori I; Richardson DR; Toyokuni S; Kishi F
    J Biol Chem; 2017 Aug; 292(32):13205-13229. PubMed ID: 28655775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin-1 is a competitive inhibitor of heme oxygenase-1 (HO-1) with heme: identification of a minimum sequence in caveolin-1 for binding to HO-1.
    Taira J; Sugishima M; Kida Y; Oda E; Noguchi M; Higashimoto Y
    Biochemistry; 2011 Aug; 50(32):6824-31. PubMed ID: 21721581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heme oxygenase-1 and NADPH cytochrome P450 reductase expression in experimental allergic encephalomyelitis: an expanded view of the stress response.
    Emerson MR; LeVine SM
    J Neurochem; 2000 Dec; 75(6):2555-62. PubMed ID: 11080209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic turnover dependent modification of the Pseudomonas aeruginosa heme oxygenase (pa-HO) by 5,6-O-isopropyledine-2-O-allyl-ascorbic acid.
    Bhakta MN; Olabisi A; Wimalasena K; Wilks A
    J Inorg Biochem; 2008 Feb; 102(2):251-9. PubMed ID: 17923157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme oxygenase isoforms differ in their subcellular trafficking during hypoxia and are differentially modulated by cytochrome P450 reductase.
    Linnenbaum M; Busker M; Kraehling JR; Behrends S
    PLoS One; 2012; 7(4):e35483. PubMed ID: 22545110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.